Clinical characteristics of patients included in this study
Doxorubicin (51) | FUMI (30) | |||
---|---|---|---|---|
Response | ||||
PD | 8 | 7 | ||
SD | 22 | 13 | ||
PR | 21 | 10 | ||
Histology | ||||
Ductal | 46 | 26 | ||
Other | 5 | 4 | ||
TP53 mutations | 24 | 16 | ||
Median age | 62 (32–85) | 64 (37–82) | ||
Median OS (mo) | 33 (7–92) | 24 (3–54) | ||
No. relapses | 26 | 17 |
Abbreviations: PD, progressive disease; SD, stable disease; PR, partial response; OS, overall survival.